Evidence map›Paper›PMID 37735222›Full record

ArticleNeuroradiology2023

Impact of cannabis use on brain metabolism using

Maximilian Fenzl, Martin Backens, Silviu Bodea, Miriam Wittemann, Florian Werler, Jule Brielmaier, Robert Christian Wolf, Wolfgang Reith

Open access · hybridAbstract read
In one paragraph

Article in Neuroradiology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
0.7field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it, 3 citations in OpenAlex.

  1. Pooled it
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Maximilian FenzlInstitute of Neuroradiology, Saarland University, 66421, Homburg, Germany. maximilian@fenzl.biz.ORCID http://orcid.org/0000-0003-1011-2754
Martin BackensInstitute of Neuroradiology, Saarland University, 66421, Homburg, Germany. martin.backens@uks.eu.ORCID https://orcid.org/0000-0002-3414-696X
Silviu BodeaHelmholtz Zentrum Munich, German Research Center for Environmental Health Institute of Biological and Medical Imaging, 85748, Munich, Germany.
Miriam WittemannDepartment of Psychiatry and Psychotherapy, Saarland University, 66421, Homburg, Germany.
Florian WerlerDepartment of General Psychiatry at the Center for Psychosocial Medicine, Heidelberg University, 69115, Heidelberg, Germany.
Jule BrielmaierDepartment of Psychiatry and Psychotherapy, Saarland University, 66421, Homburg, Germany.
Robert Christian WolfDepartment of General Psychiatry at the Center for Psychosocial Medicine, Heidelberg University, 69115, Heidelberg, Germany.ORCID https://orcid.org/0000-0002-5358-5212
Wolfgang ReithInstitute of Neuroradiology, Saarland University, 66421, Homburg, Germany.
Saarland University · DEHeidelberg University · DEHelmholtz Zentrum München · DEKlinikum Ludwigsburg · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeThis prospective cross-sectional study investigated the influence of regular cannabis use on brain metabolism in young cannabis users by using combined proton and phosphorus magnetic resonance spectroscopy.

methodsThe study was performed in 45 young cannabis users aged 18-30, who had been using cannabis on a regular basis over a period of at least 2 years and in 47 age-matched controls. We acquired 31P MRS data in different brain regions at 3T with a double-resonant 1H/31P head coil, anatomic images, and 1H MRS data with a standard 20-channel 1H head coil. Absolute concentration values of proton metabolites were obtained via calibration from tissue water as an internal reference, whereas a standard solution of 75 mmol/l KH2PO4 was used as an external reference for the calibration of phosphorus signals.

resultsWe found an overall but not statistically significant lower concentration level of several proton and phosphorus metabolites in cannabis users compared to non-users. In particular, energy-related phosphates such as adenosine triphosphate (ATP) and inorganic phosphate (Pi) were reduced in all regions under investigation. Phosphocreatine (PCr) showed lowered values mainly in the left basal ganglia and the left frontal white matter.

conclusionThe results suggest that the increased risk of functional brain disorders observed in long-term cannabis users could be caused by an impairment of the energy metabolism of the brain, but this needs to be verified in future studies.

Indexed as

BrainProton Magnetic Resonance SpectroscopyAdolescentAdultCase-Control StudiesCross-Sectional StudiesFemaleHumansMagnetic Resonance SpectroscopyMalePhosphorusPhosphorus IsotopesProspective StudiesYoung AdultPhosphorusPhosphorus Isotopes1H MRS31P MRSBrain metabolitesCannabisMarijuana

Identifiers

PMID37735222
PMCPMC10567915
OpenAlexW4386913867

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.